SCO-267 is an allosteric full agonist of the GPR40 receptor, primarily involved in enhancing insulin secretion. This compound exhibits significant potential in the study of chronic metabolic disorders, particularly diabetes mellitus. Its distinct mechanism of action enhances glucose-dependent insulin release, making it a valuable tool for investigating therapeutic strategies in diabetes management and related metabolic diseases.
SCO-267 is an allosteric full agonist of the GPR40 receptor, primarily involved in enhancing insulin secretion. This compound exhibits significant potential in the study of chronic metabolic disorders, particularly diabetes mellitus. Its distinct mechanism of action enhances glucose-dependent insulin release, making it a valuable tool for investigating therapeutic strategies in diabetes management and related metabolic diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
